BiotechTube
Transit Scientific

Transit Scientific

Salt Lake City, United States· Est.
xoscore.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Transit Scientific is a privately held, revenue-generating medical device company focused on the vascular intervention market. Its core technology, protected by a robust intellectual property portfolio (14 patents issued/allowed, 14 pending), enhances the performance of standard angioplasty balloons and provides superior catheter support in complex anatomies. The company has achieved regulatory clearance in the US and EU for its two primary platforms, which address significant unmet needs in treating PAD, CLI, and dialysis access stenosis. With a patient-first mentality and a focus on clinical efficacy, Transit Scientific is positioned to capture share in the large and growing peripheral vascular device market.

Peripheral Artery DiseaseCritical Limb IschemiaVascular AccessEmbolization

Technology Platform

Proprietary catheter-based platforms for vessel scoring/preparation (XO Score) and for lesion crossing/support/therapeutic delivery (XO Cross/XO Cath). Technology enhances performance of standard balloons and provides superior trackability in complex anatomy.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The growing global prevalence of PAD and CLI, especially complex below-the-knee disease, presents a large and expanding market.
The XO Cath's proven utility in embolization procedures opens significant new markets in interventional radiology and oncology.
The industry-wide shift toward radial access and minimally invasive techniques aligns perfectly with the performance attributes of Transit's platforms.

Risk Factors

Intense competition from large, well-capitalized medical device companies with dominant market share poses a significant commercial threat.
As a small player, the company faces execution risk in building an effective sales and distribution network.
Dependence on contract manufacturers for production introduces supply chain and quality control vulnerabilities.

Competitive Landscape

Transit Scientific competes in the crowded peripheral vascular device market against giants like Boston Scientific, Medtronic, Abbott, and Philips, as well as specialized players like BD Interventional, Cook Medical, and Cardinal Health's Cordis. Its differentiation lies in its unique scoring sheath technology (XO Score) and the high-performance crossing capabilities of its catheters (XO Cross), which are designed to address specific procedural failures in complex anatomy.

More companies in Drug Delivery & Formulation →More companies in United States →